Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.
Fluorescent Light energy. treating rosacea subtypes 1,2 and 3 / Sannino, M; Lodi, G; Nistico', S; Cannarozzo G., Nielsen M. - In: CLINICAL CASE REPORTS. - ISSN 2050-0904. - 6:12(2018), pp. 2385-2390. [10.1002/ccr3.1891]
Fluorescent Light energy. treating rosacea subtypes 1,2 and 3
Nistico' S;
2018
Abstract
Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Sannino_Fluorescent_2018.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
590.6 kB
Formato
Adobe PDF
|
590.6 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
